Home LiteratureArticle Details
PMID: 11264368 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.

Journal of virology ·Vol. 75 ·No. 8 ·2001-04-00 ·Pages 3791-801

Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, Planelles V

Abstract

All primate lentiviruses known to date contain one or two open reading frames with homology to the human immunodeficiency virus type 1 (HIV-1) vpr gene. HIV-1 vpr encodes a 96-amino-acid protein with multiple functions in the viral life cycle. These functions include modulation of the viral replication kinetics, transactivation of the long terminal repeat, participation in the nuclear import of preintegration complexes, induction of G2 arrest, and induction of apoptosis. The simian immunodeficiency virus (SIV) that infects African green monkeys (SIVagm) contains a vpr homologue, which encodes a 118-amino-acid protein. SIVagm vpr is structurally and functionally related to HIV-1 vpr. The present study focuses on how three specific functions (transactivation, induction of G2 arrest, and induction of apoptosis) are related to one another at a functional level, for HIV-1 and SIVagm vpr. While our study supports previous reports demonstrating a causal relationship between induction of G2 arrest and transactivation for HIV-1 vpr, we demonstrate that the same is not true for SIVagm vpr. Transactivation by SIVagm vpr is independent of cell cycle perturbation. In addition, we show that induction of G2 arrest is necessary for the induction of apoptosis by HIV-1 vpr but that the induction of apoptosis by SIVagm vpr is cell cycle independent. Finally, while SIVagm vpr retains its transactivation function in human cells, it is unable to induce G2 arrest or apoptosis in such cells, suggesting that the cytopathic effects of SIVagm vpr are species specific. Taken together, our results suggest that while the multiple functions of vpr are conserved between HIV-1 and SIVagm, the mechanisms leading to the execution of such functions are divergent.

MeSH Terms
Active Transport, Cell Nucleus Animals Apoptosis/drug effects COS Cells Caffeine/pharmacology Cell Cycle/drug effects Chlorocebus aethiops Flow Cytometry G2 Phase/drug effects Gene Products, vpr/genetics,metabolism Genes, vpr/genetics HIV Long Terminal Repeat/genetics HIV-1/genetics Humans Mitosis/drug effects Models, Biological Paclitaxel/pharmacology Simian Immunodeficiency Virus/genetics Transcriptional Activation/drug effects Transduction, Genetic Tumor Cells, Cultured vpr Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, vpr vpr Gene Products, Human Immunodeficiency Virus Caffeine Paclitaxel
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Zhu Y
Department of Medicine, University of Rochester Cancer Center, Rochester, New York 14642, USA.
Gelbard H A
Roshal M
Pursell S
Jamieson B D
Planelles V
References (57)
57 references, click to expand
  1. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).
    J Virol. 1999 Dec;73(12):9992-9 PMID: 10559313
  2. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest.
    J Biol Chem. 1998 Nov 13;273(46):30777-84 PMID: 9804855
  3. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.
    J Virol. 2000 Jan;74(2):652-60 PMID: 10623726
  4. Differential apoptosis effects of primate lentiviral Vpr and Vpx in mammalian cells.
    J Biomed Sci. 2000 Jul-Aug;7(4):322-33 PMID: 10895056
  5. Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells.
    Exp Cell Res. 2000 Aug 1;258(2):261-9 PMID: 10896777
  6. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
    J Biol Chem. 2000 Nov 10;275(45):35209-14 PMID: 10931842
  7. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  8. Mutational analysis of the human immunodeficiency virus vpr open reading frame.
    J Virol. 1989 Sep;63(9):4110-4 PMID: 2474678
  9. Checkpoints: controls that ensure the order of cell cycle events.
    Science. 1989 Nov 3;246(4930):629-34 PMID: 2683079
  10. Identification of HIV-1 vpr product and function.
    J Acquir Immune Defic Syndr. 1990;3(1):11-8 PMID: 2136707
  11. Human immunodeficiency virus vpr product is a virion-associated regulatory protein.
    J Virol. 1990 Jun;64(6):3097-9 PMID: 2139896
  12. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens.
    J Immunol. 1990 Sep 15;145(6):1952-9 PMID: 2118158
  13. Human immunodeficiency virus vpr gene encodes a virion-associated protein.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1265-71 PMID: 2150318
  14. Evolution of the primate lentiviruses: evidence from vpx and vpr.
    EMBO J. 1992 Sep;11(9):3405-12 PMID: 1324171
  15. Biological basis for cancer treatment.
    Ann Intern Med. 1993 Apr 15;118(8):633-7 PMID: 8452330
  16. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7 PMID: 8396259
  17. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.
    Cell. 1993 Sep 24;74(6):957-67 PMID: 8402885
  18. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate.
    Virology. 1994 May 1;200(2):623-31 PMID: 8178448
  19. Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.
    EMBO J. 1994 Jun 15;13(12):2935-47 PMID: 8026477
  20. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
    Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7311-5 PMID: 8041786
  21. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase.
    Cancer Res. 1994 Aug 15;54(16):4355-61 PMID: 7913875
  22. Paclitaxel: a new antimitotic chemotherapeutic agent.
    Cancer Pract. 1994 Jan-Feb;2(1):27-33 PMID: 7914453
  23. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.
    J Virol. 1995 Feb;69(2):882-8 PMID: 7815556
  24. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Virology. 1995 Feb 1;206(2):935-44 PMID: 7531918
  25. Taxol (paclitaxel): mechanisms of action.
    Ann Oncol. 1994;5 Suppl 6:S3-6 PMID: 7865431
  26. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.
    J Virol. 1995 Sep;69(9):5883-9 PMID: 7637036
  27. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.
    J Virol. 1995 Oct;69(10):6304-13 PMID: 7666531
  28. A new reporter system for detection of retroviral infection.
    Gene Ther. 1995 Aug;2(6):369-76 PMID: 7584111
  29. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
    J Virol. 1995 Nov;69(11):6705-11 PMID: 7474080
  30. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
    J Virol. 1995 Nov;69(11):6859-64 PMID: 7474100
  31. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
    J Virol. 1995 Dec;69(12):7909-16 PMID: 7494303
  32. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.
    J Virol. 1996 Feb;70(2):1027-32 PMID: 8551560
  33. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
    Science. 1996 Apr 12;272(5259):263-7 PMID: 8602510
  34. Vpr-induced cell cycle arrest is conserved among primate lentiviruses.
    J Virol. 1996 Apr;70(4):2516-24 PMID: 8642681
  35. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.
    J Virol. 1996 Apr;70(4):2581-5 PMID: 8642689
  36. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11382-8 PMID: 8876144
  37. When checkpoints fail.
    Cell. 1997 Feb 7;88(3):315-21 PMID: 9039258
  38. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard.
    J Virol. 1997 May;71(5):3961-71 PMID: 9094673
  39. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology.
    J Virol. 1997 Jun;71(6):4331-8 PMID: 9151821
  40. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.
    J Virol. 1997 Jul;71(7):5579-92 PMID: 9188632
  41. Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes.
    J Virol. 1997 Jul;71(7):5593-602 PMID: 9188633
  42. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
    J Virol. 1997 Sep;71(9):6339-47 PMID: 9261351
  43. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
    Nat Med. 1998 Jan;4(1):65-71 PMID: 9427608
  44. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages.
    J Exp Med. 1998 Apr 6;187(7):1103-11 PMID: 9529326
  45. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase.
    J Biol Chem. 1998 May 8;273(19):11944-53 PMID: 9565623
  46. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.
    J Mol Biol. 1998 Apr 24;278(1):13-30 PMID: 9571031
  47. G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation.
    Radiat Res. 1999 Jun;151(6):659-69 PMID: 10360785
  48. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.
    J Virol. 1999 Jul;73(7):5422-30 PMID: 10364289
  49. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    J Hum Virol. 1999 May-Jun;2(3):167-74 PMID: 10413368
  50. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.
    Exp Cell Res. 1999 Aug 25;251(1):156-65 PMID: 10438581
  51. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication.
    J Virol. 1999 Sep;73(9):7671-7 PMID: 10438857
  52. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.
    J Biol Chem. 1998 May 22;273(21):13347-52 PMID: 9582382
  53. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.
    J Virol. 1998 Jul;72(7):6004-13 PMID: 9621063
  54. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus.
    J Virol. 1998 Aug;72(8):6520-6 PMID: 9658095
  55. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.
    J Biol Chem. 1998 Jul 24;273(30):18984-91 PMID: 9668078
  56. A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
    J Immunol. 1998 Oct 1;161(7):3729-36 PMID: 9759898
  57. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
    Mol Cell Biol. 1999 Dec;19(12):8469-78 PMID: 10567572
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-04-00
Pages
3791-801
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114870
Subset
IM
Grants
NIMH NIH HHS · R01 MH056838 · United States
NIMH NIH HHS · 5RO1-MH56838 · United States
NIAID NIH HHS · R29-AI41407 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com